Skip to main content
Home

Breadcrumb

  1. Home
  2. Pharma

Pharma

4 August 2026

Cambridge – South Carolina Collaboration Opportunities in Life Sciences

One Nucleus serves to bring attention, insight and connectivity to potential growth and collaboration opportunities for its members and wider network. An example has arisen with a visit to the UK of a high-level delegation from South Carolina which includes James Chappell, CEO SCBIO, Ph...

4 August 2026

BioBeat25: Getting ahead of the curve in biotech

Leaders in life sciences will discuss success in biotech through forward-thinking. Biotech and Partnering Hotspots will explore key areas, where partnerships tend to be struck and the drivers behind such deals. Nailing the Fundraise will discuss the practical side of closing a financing...

Podcast Studio Production Cambridge
10 April 2025

WaveFX uses AI Podcast presenters in new Spotify series

WaveFX podcast studio is embracing AI podcast presenters, offering clients an innovative new way to create content. The launch coincides with their brand-new 12-part AI-hosted podcast series, now available on Spotify. ...

The Role of AI and Omnichannel Strategies in Healthcare Marketing
10 April 2025

The role of AI and omnichannel strategies in healthcare marketing

Co-authored by Jose Maria (Chema) Guido Avila, SanofiThe pharmaceutical industry is at a pivotal moment. As the world grows more digital and patients become more informed, traditional marketing strategies are losing their effectiveness. Doctors are overwhelmed with information, and pati...

Dr Del Trezise, Chair of ELRIG
8 April 2025

ELRIG appoints Dr Del Trezise as Chair

Cambridge, UK, 8 April 2025: ELRIG, a not-for-profit, volunteer-led organisation dedicated to the drug discovery community, has appointed Dr Del Trezise as Chair of the Board. In this role, he will lead ELRIG’s mission to foster collaboration, innovation, and knowledge-sh...

4 August 2026

Future Farms: Vertical Growing, Insect Cultivation & DIY Biologicals

Diversifying farm production: from DIY biologicals, to home-grown insects, and modular crop production. ...

4 August 2026

ELRIG Therapeutic Oligonucleotides 2025

The second ELRIG meeting on Therapeutic Oligonucleotides, scheduled for May 14-15, 2025, will be hosted at the AstraZeneca R&D site in Gothenburg. This dynamic event aims to build upon the success of the inaugural Therapeutic Oligonucleotides meeting and the well-regarded Advances i...

Catalyser
31 March 2025

Applications are open for Catalyser 2025, SBC's free accelerator programme

Are you a pre-clinical therapeutics start-up? Stevenage Bioscience Catalyst’s Catalyser programme is an accelerator designed to help businesses attract investors and partners, and maximise overall chances of commercial success. ...

GKN
31 March 2025

How to overcome the challenges of constructing a new cleanroom in an old facility

UK-based contamination control experts the Guardtech Group have a long history of turning tired, old premises into stunning new homes for a wide range of applications ...

ELIRG Logo
25 March 2025

ELRIG announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025

Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from 14–15 May ...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 31
  • Page 32
  • Current page 33
  • Page 34
  • Page 35
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS